Therefore, we evaluated the clinical prognostic significance of the β2-AR overexpression in the patients with Her2-positive breast cancers by retrospectively investigating the relationship between the level of β2-AR and DFS or OS of the patients. Here, ERBB2 is linked to breast cancer.